Degradation of thyrotropin-releasing hormone by the GH3 strain of pituitary cells in culture
- PMID: 169122
- DOI: 10.1210/endo-97-2-324
Degradation of thyrotropin-releasing hormone by the GH3 strain of pituitary cells in culture
Abstract
Thyrotropin-releasing hormone (TRH), pGlu-His-ProNH2, binds within 1 h to specific receptors on the GH3 strain of pituitary cells. When GH3 cells were incubated for 2 days with 3 nM [2,3-3H-Pro]TRH, an increasing fraction of the total cellular radioactivity (7% after 1 h, 81% after 43 h) was associated covalently with proteins as determined by dialysis, acid precipitation, and gel filtration; this fraction corresponded to label which could not be displaced from intact GH3 cells by the addition of excess unlabeled TRH. R5 and GH12C1 cells, strains which lack TRH receptors, accumulated 16 or 23%, respectively, as much label from [2,3-3H-Pro]TRH as did GH3 cells in 24 h. After 24 h of incubation with [2,3-3H-Pro]TRH and [14C-His]TRH, the ratio of 14C/3H in GH3 cells was the same as in the culture medium, indicating that the intact tripeptide was taken up by the cells. After 24-48 h of incubation with [2,3-3H-Pro]TRH, GH3 proteins appeared to be labeled randomly as surmised by fractionation on Sephadex G-100, DEAE cellulose, Sepharose 4B and sucrose density gradients. In cultures treated with cycloheximide (10 mug/ml) or proline (6.3 mM) the initial binding of [2,3-3H-Pro]TRH to receptors, measured after 1 h, was 97% or 102% of control. However, the incorporation of label from [2,3-3H-Pro]TRH into an acid-precipitable product after 22 h was inhibited by 81 and 74% by cycloheximide (1 mug/ml) and proline (2.5 mM). Formation of [2,3-3H] proline from [2,3-?3H-Pro] TRH was demonstrated by thin layer chromatography; the percentage of non-protein radioactivity with an Rf of proline increased from 20 to 80% in GH3 cells incubated 1 or 24 h with [2,3-3H-Pro]TRH. We conclude that after binding to receptors on GH3 cells, TRH is slowly metabolized to its constituent amino acids, and the products [2,3-3H]proline or [14C]histidine are incorporated into newly synthesized proteins.
Similar articles
-
Thyrotropin-releasing hormone regulates the number of its own receptors in the GH3 strain of pituitary cells in culture.Biochemistry. 1975 Aug 26;14(17):3845-51. doi: 10.1021/bi00688a017. Biochemistry. 1975. PMID: 169886
-
Fate of thyrotropin releasing hormone after binding and stimulation of prolactin release by GH3 cells. Evidence for release of unmodified (3H)-TRH.Neuroendocrinology. 1976;20(3):201-11. doi: 10.1159/000122484. Neuroendocrinology. 1976. PMID: 822368
-
Thyrotropin-releasing hormone-stimulated [3H]inositol metabolism in GH3 pituitary tumor cells. Studies with lithium.Mol Pharmacol. 1984 Mar;25(2):201-8. Mol Pharmacol. 1984. PMID: 6321943
-
Is all cyclo(His-Pro) derived from thyrotropin-releasing hormone?Neurochem Res. 1987 Sep;12(9):767-74. doi: 10.1007/BF00971513. Neurochem Res. 1987. PMID: 3118225 Review.
-
Histidyl-proline diketopiperazine: its biological role as a regulatory peptide.Mol Cell Biochem. 1982 Jan 16;42(1):45-63. doi: 10.1007/BF00223538. Mol Cell Biochem. 1982. PMID: 6278283 Review.
Cited by
-
Direct visualization of receptors for thyrotropin-releasing hormone with a fluorescein-labeled analog.Proc Natl Acad Sci U S A. 1981 Jan;78(1):587-91. doi: 10.1073/pnas.78.1.587. Proc Natl Acad Sci U S A. 1981. PMID: 6264450 Free PMC article.
-
Evidence that the thyrotropin-releasing hormone receptor and its ligand are recycled dissociated from each other.Biochem J. 1995 Feb 15;306 ( Pt 1)(Pt 1):107-13. doi: 10.1042/bj3060107. Biochem J. 1995. PMID: 7864795 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources